Raimund Strehl, PhD

VERIGRAFT AB
Göteborg, Vastra Gotaland, Sweden

Disclosure information not submitted.

Presentation(s):

• Phase I, open-label, first-in-human study to evaluate the safety and feasibility of personalized tissue-engineered vein grafts in patients with chronic venous insufficiency.

  Wednesday, February 19, 2025
  11:27 AM – 11:33 AM EST